Want to join the conversation?
$MDLZ 2Q15 PR: MDLZ reported net revenues of $7,661MM vs. $8,436MM in 2Q14. Net earnings attributable to MDLZ were $406MM vs. $622MM and diluted EPS attributable to MDLZ was $0.25, down $0.11 vs. $0.36 in 2Q14. Net revenues decreased 9.2% due to currency. Adjusted gross profit margin was 40.2%, up 330 BP.
$YHOO is reporting today after market close. Nobody cares about this stock.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.